-
1 Comment
Haisco Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 8.1% below its 200 day moving average.
From a valuation standpoint, the stock is 9.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.7.
Haisco Pharmaceutical Group Co., Ltd's total revenue rose by 0.4% to $954M since the same quarter in the previous year.
Its net income has increased by 111.3% to $234M since the same quarter in the previous year.
Finally, its free cash flow fell by 119.2% to $-21M since the same quarter in the previous year.
Based on the above factors, Haisco Pharmaceutical Group Co., Ltd gets an overall score of 3/5.
| Industry | Biotechnology |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100001BC7 |
| Sector | Healthcare |
| Beta | -0.03 |
|---|---|
| Market Cap | 49B |
| PE Ratio | 136.19 |
| Target Price | 59.54 |
| Dividend Yield | 1.0% |
Haisco Pharmaceutical Group Co., Ltd. research, develops, manufactures, and sells pharmaceuticals in China. The company offers cycloporol, dolasetron mesylate, polyene phosphatidylcholine, compound amino acid, and methylprednisolone sodium injections, as well as flupenthixol melitracen tablets. It offers its products in various therapeutic fields, including anesthesia, parenteral nutrition, tumor antiemetic, liver, gallbladder digestion, antibiotics, cardiovascular, and cerebrovascular. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Shannan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002653.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
